> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Panel to Review Gadolinium Retention in Contrast Agents
- URL: https://www.fdaweb.com/panel-to-review-gadolinium-retention-in-contrast-agents/
- Published: 2017-08-10T12:00:00.000Z
- Updated: 2026-09-14T22:40:28.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5139354

*Federal Register* notice: FDA has announced a 9/8 Medical Imaging Drugs Advisory Committee meeting. Panel members will discuss the potential risk of gadolinium retention in the brain and other body organs in patients receiving gadolinium-based contrast agents for magnetic resonance clinical imaging procedures. To view the notice, click [here](https://www.gpo.gov/fdsys/pkg/FR-2017-08-10/pdf/2017-16891.pdf?ref=fdaweb.com).